IlDong Pharmaceutical announced earnings results for the third quarter of fiscal 2015. For the quarter, the company announced a 12.1% rise year on year in third-quarter revenue to KRW 116.02 billion (USD 102.3 million), compared with KRW 103.51 billion for the same period the previous year. Operating profit was KRW 6.26 billion for the quarter, up 29.3% year on year from KRW 4.84 billion in the same period a year ago.

Net profit rose 26.6% year on year to KRW 5.67 billion, versus KRW 4.48 billion a year earlier.